Developer docs
API playgroundTry for free, no card

Search company profiles

Univfy

Full company profile

uuid0000gpz

Namestring
Univfy
Legal namestring
UNIVFY Inc.
Websiteurl
univfy.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Univfy is a private, venture-backed healthcare AI company headquartered in Los Altos, California, that builds machine-learning models to predict individualized IVF live birth probabilities. Founded by Stanford University researchers Dr. Mylene Yao (CEO) and Professor Wing H. Wong (Scientific Advisor), the company developed its proprietary Machine Learning Center-Specific (MLCS) modeling approach to address the limitations of age-based and national registry (SART) predictions. The platform is protected by US Patent 9,458,495B2 and corresponding foreign patents, and its methods have been validated in peer-reviewed journals including Nature Communications, Fertility and Sterility, PNAS, and Reproductive Biomedicine Online.

The company operates a B2B SaaS model with two commercial products layered on a single underlying AI platform. The Univfy PreIVF Report delivers personalized probability-of-success reports to patients counseled by fertility specialists in the Univfy Provider Network, drawing on each patient's holistic health profile and the fertility center's own clinical outcomes data. The Univfy-Powered IVF Refund Program uses those predictions to qualify 50-80% of patients for value-based refund or multi-cycle discount programs, compared with very low qualification rates under traditional shared-risk programs. Reported outcomes include more than 95% prediction accuracy, 2-5x IVF conversion lift for providers, and up to 30% revenue increase for participating fertility centers.

Univfy generates revenue primarily through subscription licensing of its platform to fertility centers and providers in the US, Canada, and the EU, with a secondary go-to-market motion targeting employers and health plans seeking cost-predictable fertility benefits. The company is HIPAA- and GDPR-compliant and reports prior FDA submission experience plus EU MDD/MDR certification experience. Across its funding history it has raised roughly $25 million in aggregate through six rounds, with the most recent being a $6 million Series B led by a portfolio company of Atlantic Street Capital in December 2021.

Short descriptiontext

Univfy is an AI/ML platform company that delivers personalized IVF success predictions and value-based refund programs to fertility centers, employers, and health plans across the US, Canada, and the EU.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Altos, United States
HQ citystring
Los Altos
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVF prediction platform, fertility treatment analytics, AI fertility prognostics, IVF refund programs, reproductive health AI
Industry2 codes
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Misc Health & Allied Services, Nec8090
Product category
Fertility Treatment Prediction Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Platform Licensing to Fertility Centers
TypeSubscription Recurring
Description

Univfy generates revenue by providing its AI/ML platform to fertility centers through a B2B model. Fertility centers pay for access to the platform to support patient counseling, clinical analytics, and business analytics including CRM tools.

univfy.com
2Enterprise Health Plan Partnerships
TypeSubscription Recurring
Description

Plans to extend services to health plans and employers who want to offer IVF benefits to members/employees. The platform is scaled to support enterprise-level health plans and benefits programs.

prnewswire.com
3Value-Based IVF Pricing Programs
TypeTransaction Fee
Description

Fertility centers use Univfy's prediction models to develop special pricing programs (IVF refund programs, multi-cycle discount programs) that qualify 50-80% of patients, creating a value-based pricing structure.

univfy.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details2 tiers
1Univfy PreIVF Report - Complimentary for Patients
ModelFreemiumBilling cadenceMonthly
Notes

Patients receive the personalized PreIVF Report free of charge from fertility specialists in the Univfy Network. Revenue comes from B2B arrangements with fertility centers.

2IVF Refund Program Qualification
ModelOutcome Based/ PerformanceBilling cadencePay-as-you-go
Notes

Univfy-powered providers can qualify 50-80% of patients for IVF refund programs, enabling more affordable multi-cycle treatment plans. Pricing varies by provider and geography.

univfy.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Univfy PreIVF Report
Description

Personalized IVF success prediction report that shows patients their probability of having a baby from IVF based on their holistic health profile and their fertility center's data.

univfy.com
+1 more record
Core offering1 text field

Univfy develops and commercializes an AI/ML platform that delivers personalized IVF success predictions to fertility centers, healthcare providers, employers, and health plans. The platform powers two primary offerings: the Univfy PreIVF Report (a personalized patient counseling report providing individual probability of having a baby from IVF) and the Univfy-Powered IVF Refund Program (a value-based financial program qualifying 50-80% of patients for refund offers). Revenue is generated B2B from fertility centers and providers accessing the platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • More than 95% accuracy in predicting IVF success rates
+7 more records
Product overview1 text field

Univfy offers a platform-plus-products architecture centered on its proprietary AI/ML Platform for IVF, which powers two primary commercial products: the Univfy PreIVF Report (a personalized patient counseling report delivering individual IVF success probabilities validated against each fertility center's own data) and the Univfy-Powered IVF Refund Program (a financial program that uses AI predictions to qualify patients for refund offers). The platform enables fertility centers to offer personalized counseling and value-based pricing, with the PreIVF Report serving as the core patient-facing deliverable and the Refund Program building on its predictions to support financial accessibility.

Product and service3 records
1Univfy PreIVF Report
CategoryPatient Counseling Report
Description

A scientifically validated personalized report that provides each patient their probability of having a baby with IVF in the first three cycles, based on their holistic health profile and the fertility center's own clinical data. The report is delivered to patients by fertility specialists in the Univfy Network at no cost.

2Univfy-Powered IVF Refund Program
CategoryFinancial/Value-based Care Program
Description

A financial program enabled by ML-based IVF predictions that qualifies 50-80% of patients for refund offers, compared to traditional refund programs that qualify only a few patients. Helps patients afford multiple IVF treatments to maximize chances of having a baby while reducing financial risk.

3Univfy AI/ML Platform for IVF
CategoryAI/ML Platform
Description

The underlying AI/machine learning platform that develops and validates center-specific prediction models for fertility centers. The platform transforms raw clinical data into patient counseling reports and value-based IVF pricing solutions. Used by fertility centers in the US, Canada, and EU to support patient counseling, clinical analytics, and business analytics.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Atlantic Reproductive Medicine Specialists
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study analyzing variation of patient clinical profiles across 9 fertility centers at 33 sites in 11 US states and Ontario, Canada.

univfy.com
2Fertility Center of San Antonio
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator and fertility center network participant. Dr. Joseph Martin (Medical Director and Founder) and Dr. Matthew G. Retzloff are featured users of the Univfy platform.

univfy.com
3Piedmont Reproductive Endocrinology Group (PREG)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study. Dr. John Payne featured as provider testimonial for Univfy PreIVF Report.

univfy.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study and fertility center network participant.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study analyzing inter-center variation of patient clinical profiles.

6POMA Fertility
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study.

univfy.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study with sites in Ontario, Canada.

9Fertility Center of Chattanooga
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator in multi-center study.

univfy.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Alife Health applies AI to IVF treatment decisions, including embryo selection and IVF optimization. It is the closest direct competitor to Univfy's AI-driven fertility prediction platform, targeting the same provider buyers with adjacent decision-support products.

TypeDirect peer
Description

TMRW Life Sciences provides AI-enabled automated cryo-storage and embryology workflow tools for IVF clinics. While focused on embryo storage rather than success prediction, it sells into the same fertility-center buyer and overlaps in digital transformation of IVF lab operations.

TypeDirect peer
Description

Overture Life is building AI and automation for IVF embryology, including automated ICSI and embryo assessment. It competes with Univfy for the same fertility-center AI budget and shares the thesis that automation and prediction will reshape IVF economics.

TypeBroad incumbent
Description

Progyny is a leading US fertility benefits management platform serving employers and health plans. It is a broader incumbent that could integrate or partner with prediction tools like Univfy's, and competes for the same employer-fertility-benefits wallet.

TypeBroad incumbent
Description

Carrot Fertility provides a global fertility and family-building benefits platform for employers and health plans. It overlaps with Univfy's employer GTM motion and is a potential channel partner or competitor for value-based IVF pricing solutions.

TypeBroad incumbent
Description

Maven Clinic is a large virtual care platform for women's and family health, including fertility, pregnancy, and postpartum. It serves employer-sponsored benefits and competes for the same employer benefits RFPs as Univfy, while offering broader scope than pure IVF prediction.

TypeEmerging player
Description

Kindbody operates tech-enabled fertility clinics and employer-facing fertility benefits. It is an emerging vertically integrated player that competes with Univfy on employer benefits and could in-source AI prediction capabilities over time.

TypeEmerging player
Description

Future Family offers fertility financing and subscription plans, including IVF refund-style programs. It overlaps with Univfy's refund-program value proposition and shares the goal of making multi-cycle IVF financially accessible.

TypeRegional player
Description

Genea Biomedx (part of Australia's Genea group) develops ART lab technologies and clinical software for IVF clinics across APAC. It is a regional peer serving the same fertility-center buyer as Univfy in geographies where Univfy is not yet present.

TypeOthers
Description

Glow operates consumer-facing fertility tracking apps and an analytics platform. While not a direct competitor to Univfy's B2B IVF prediction platform, it sits in the same fertility AI/data ecosystem and could become a consumer-side complement or competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Univfy

Fertility Treatment Prediction Softwareunivfy.com

Univfy is an AI/ML platform company that delivers personalized IVF success predictions and value-based refund programs to fertility centers, employers, and health plans across the US, Canada, and the EU.

What Univfy does

Univfy is a private, venture-backed healthcare AI company headquartered in Los Altos, California, that builds machine-learning models to predict individualized IVF live birth probabilities. Founded by Stanford University researchers Dr. Mylene Yao (CEO) and Professor Wing H. Wong (Scientific Advisor), the company developed its proprietary Machine Learning Center-Specific (MLCS) modeling approach to address the limitations of age-based and national registry (SART) predictions. The platform is protected by US Patent 9,458,495B2 and corresponding foreign patents, and its methods have been validated in peer-reviewed journals including Nature Communications, Fertility and Sterility, PNAS, and Reproductive Biomedicine Online.

The company operates a B2B SaaS model with two commercial products layered on a single underlying AI platform. The Univfy PreIVF Report delivers personalized probability-of-success reports to patients counseled by fertility specialists in the Univfy Provider Network, drawing on each patient's holistic health profile and the fertility center's own clinical outcomes data. The Univfy-Powered IVF Refund Program uses those predictions to qualify 50-80% of patients for value-based refund or multi-cycle discount programs, compared with very low qualification rates under traditional shared-risk programs. Reported outcomes include more than 95% prediction accuracy, 2-5x IVF conversion lift for providers, and up to 30% revenue increase for participating fertility centers.

Univfy generates revenue primarily through subscription licensing of its platform to fertility centers and providers in the US, Canada, and the EU, with a secondary go-to-market motion targeting employers and health plans seeking cost-predictable fertility benefits. The company is HIPAA- and GDPR-compliant and reports prior FDA submission experience plus EU MDD/MDR certification experience. Across its funding history it has raised roughly $25 million in aggregate through six rounds, with the most recent being a $6 million Series B led by a portfolio company of Atlantic Street Capital in December 2021.

Univfy firmographics

Firmographics
Name
Univfy
Legal name
UNIVFY Inc.
Website
https://univfy.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Univfy is an AI/ML platform company that delivers personalized IVF success predictions and value-based refund programs to fertility centers, employers, and health plans across the US, Canada, and the EU.
Ownership category
akta.pro rank

Univfy industry classification

Industry
Product category
Fertility Treatment Prediction Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)

Keywords

  • IVF prediction platform
  • Fertility treatment analytics
  • AI fertility prognostics
  • IVF refund programs
  • Reproductive health AI

Where Univfy is headquartered

Location

Headquarters

HQ city
Los Altos
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Univfy business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. B2B Platform Licensing to Fertility Centers: Univfy generates revenue by providing its AI/ML platform to fertility centers through a B2B model. Fertility centers pay for access to the platform to support patient counseling, clinical analytics, and business analytics including CRM tools.
  2. Enterprise Health Plan Partnerships: Plans to extend services to health plans and employers who want to offer IVF benefits to members/employees. The platform is scaled to support enterprise-level health plans and benefits programs.
  3. Value-Based IVF Pricing Programs: Fertility centers use Univfy's prediction models to develop special pricing programs (IVF refund programs, multi-cycle discount programs) that qualify 50-80% of patients, creating a value-based pricing structure.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyUnivfy PreIVF Report - Complimentary for Patients
Outcome Based/ PerformancePay-as-you-goIVF Refund Program Qualification

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Univfy product offering

Product offering

Core offering

Univfy develops and commercializes an AI/ML platform that delivers personalized IVF success predictions to fertility centers, healthcare providers, employers, and health plans. The platform powers two primary offerings: the Univfy PreIVF Report (a personalized patient counseling report providing individual probability of having a baby from IVF) and the Univfy-Powered IVF Refund Program (a value-based financial program qualifying 50-80% of patients for refund offers). Revenue is generated B2B from fertility centers and providers accessing the platform.

Product overview

Univfy offers a platform-plus-products architecture centered on its proprietary AI/ML Platform for IVF, which powers two primary commercial products: the Univfy PreIVF Report (a personalized patient counseling report delivering individual IVF success probabilities validated against each fertility center's own data) and the Univfy-Powered IVF Refund Program (a financial program that uses AI predictions to qualify patients for refund offers). The platform enables fertility centers to offer personalized counseling and value-based pricing, with the PreIVF Report serving as the core patient-facing deliverable and the Refund Program building on its predictions to support financial accessibility.

Differentiator

Problem solved

Functional benefit

Brands

  • Univfy PreIVF Report: Personalized IVF success prediction report that shows patients their probability of having a baby from IVF based on their holistic health profile and their fertility center's data.
  • Univfy-Powered IVF Refund Program

Products and services

  • Univfy PreIVF Report A scientifically validated personalized report that provides each patient their probability of having a baby with IVF in the first three cycles, based on their holistic health profile and the fertility center's own clinical data. The report is delivered to patients by fertility specialists in the Univfy Network at no cost.
  • Univfy-Powered IVF Refund Program A financial program enabled by ML-based IVF predictions that qualifies 50-80% of patients for refund offers, compared to traditional refund programs that qualify only a few patients. Helps patients afford multiple IVF treatments to maximize chances of having a baby while reducing financial risk.
  • Univfy AI/ML Platform for IVF The underlying AI/machine learning platform that develops and validates center-specific prediction models for fertility centers. The platform transforms raw clinical data into patient counseling reports and value-based IVF pricing solutions. Used by fertility centers in the US, Canada, and EU to support patient counseling, clinical analytics, and business analytics.

Quantifiable outcome

  • More than 95% accuracy in predicting IVF success rates
  • +7 more outcomes

Companies that use Univfy

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Univfy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Univfy partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered minor.

  • Atlantic Reproductive Medicine SpecialistsminorStrategic or Co-development PartnerResearch collaborator in multi-center study analyzing variation of patient clinical profiles across 9 fertility centers at 33 sites in 11 US states and Ontario, Canada.
  • Fertility Center of San AntoniominorStrategic or Co-development PartnerResearch collaborator and fertility center network participant. Dr. Joseph Martin (Medical Director and Founder) and Dr. Matthew G. Retzloff are featured users of the Univfy platform.
  • Piedmont Reproductive Endocrinology Group (PREG)minorStrategic or Co-development PartnerResearch collaborator in multi-center study. Dr. John Payne featured as provider testimonial for Univfy PreIVF Report.
  • Gago Center for FertilityminorStrategic or Co-development PartnerResearch collaborator in multi-center study and fertility center network participant.
  • NewLIFE FertilityminorStrategic or Co-development PartnerResearch collaborator in multi-center study analyzing inter-center variation of patient clinical profiles.
  • POMA FertilityminorStrategic or Co-development PartnerResearch collaborator in multi-center study.
  • SpingCreek FertilityminorStrategic or Co-development PartnerResearch collaborator in multi-center study.
  • TRIO Fertility (Canada)minorStrategic or Co-development PartnerResearch collaborator in multi-center study with sites in Ontario, Canada.
  • Fertility Center of ChattanoogaminorStrategic or Co-development PartnerResearch collaborator in multi-center study.

Scale indicators11 records

Recent moves5 records

Expansion highlights3 records

Univfy competitors and assessment

Company assessment

Direct peers

  • Alife Health: Alife Health applies AI to IVF treatment decisions, including embryo selection and IVF optimization. It is the closest direct competitor to Univfy's AI-driven fertility prediction platform, targeting the same provider buyers with adjacent decision-support products.
  • TMRW Life Sciences: TMRW Life Sciences provides AI-enabled automated cryo-storage and embryology workflow tools for IVF clinics. While focused on embryo storage rather than success prediction, it sells into the same fertility-center buyer and overlaps in digital transformation of IVF lab operations.
  • Overture Life: Overture Life is building AI and automation for IVF embryology, including automated ICSI and embryo assessment. It competes with Univfy for the same fertility-center AI budget and shares the thesis that automation and prediction will reshape IVF economics.

Broad incumbents

  • Progyny: Progyny is a leading US fertility benefits management platform serving employers and health plans. It is a broader incumbent that could integrate or partner with prediction tools like Univfy's, and competes for the same employer-fertility-benefits wallet.
  • Carrot Fertility: Carrot Fertility provides a global fertility and family-building benefits platform for employers and health plans. It overlaps with Univfy's employer GTM motion and is a potential channel partner or competitor for value-based IVF pricing solutions.
  • Maven Clinic: Maven Clinic is a large virtual care platform for women's and family health, including fertility, pregnancy, and postpartum. It serves employer-sponsored benefits and competes for the same employer benefits RFPs as Univfy, while offering broader scope than pure IVF prediction.

Emerging players

  • Kindbody: Kindbody operates tech-enabled fertility clinics and employer-facing fertility benefits. It is an emerging vertically integrated player that competes with Univfy on employer benefits and could in-source AI prediction capabilities over time.
  • Future Family: Future Family offers fertility financing and subscription plans, including IVF refund-style programs. It overlaps with Univfy's refund-program value proposition and shares the goal of making multi-cycle IVF financially accessible.

Regional players

  • Genea Biomedx: Genea Biomedx (part of Australia's Genea group) develops ART lab technologies and clinical software for IVF clinics across APAC. It is a regional peer serving the same fertility-center buyer as Univfy in geographies where Univfy is not yet present.

Others

  • Glow, Inc. Glow operates consumer-facing fertility tracking apps and an analytics platform. While not a direct competitor to Univfy's B2B IVF prediction platform, it sits in the same fertility AI/data ecosystem and could become a consumer-side complement or competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Univfy social profiles

Digital presence

Univfy compliance and trust

Trust signal

Compliance2 records

Univfy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Univfy leadership team

Management profile

Number of profiles

Profiles4 records

Univfy funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Univfy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Univfy

What does Univfy do?

Univfy develops and commercializes an AI/ML platform that delivers personalized IVF success predictions to fertility centers, healthcare providers, employers, and health plans. The platform powers two primary offerings: the Univfy PreIVF Report (a personalized patient counseling report providing individual probability of having a baby from IVF) and the Univfy-Powered IVF Refund Program (a value-based financial program qualifying 50-80% of patients for refund offers). Revenue is generated B2B from fertility centers and providers accessing the platform.

Is Univfy a public or private company?

Univfy is a private company. It is classified as venture growth investor backed and is currently operating.

When was Univfy founded?

Univfy was founded in 2013. It employs 1 to 10 people.

Where is Univfy based?

Univfy is headquartered in Los Altos, United States, in the North America region.

How does Univfy make money?

Three revenue lines are on record. B2B Platform Licensing to Fertility Centers are the primary driver. The others are enterprise Health Plan Partnerships and value-Based IVF Pricing Programs.

Who are Univfy's main competitors?

Direct peers on record are Alife Health, TMRW Life Sciences and Overture Life. Broad incumbents are Progyny, Carrot Fertility and Maven Clinic. Emerging players are Kindbody and Future Family. Genea Biomedx is listed as a regional player. Glow, Inc. is listed as an others.

Does Univfy have an API?

No public API is recorded for Univfy.

What industry is Univfy in?

Univfy's product category is Fertility Treatment Prediction Software. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureMachine learning center-specific models show improved IVF live birth predictions over US national registry-based modelA retrospective validation study compared machine learning center-specific (MLCS) models developed by Univfy Inc. with the Society for Assisted Reproductive Technology (SART) national registry-based model for IVF live birth prediction using 4,635 patients' first-IVF cycle data from 6 US fertility centers. MLCS models demonstrated significantly improved performance over SART, with higher precision-recall area-under-the-curve and F1 scores at the 50% LBP threshold, and better calibration as measured by Brier scores. The study found that MLCS appropriately assigned 23% and 11% of patients to higher prognostic categories (LBP ≥50% and ≥75% respectively) compared to SART's lower predictions, with actual live birth rates validating MLCS's more accurate prognoses.PR NewswireUnivfy and LightStream Launch Program to Make Having a Baby More Attainable for the Growing Number of People Who Rely on Fertility Care to Have a FamilyUnivfy and LightStream (a division of Truist Bank) have launched a joint fertility financing program combining AI-powered IVF success prediction with unsecured loans up to $100,000 for treatment costs. The program addresses key barriers to fertility treatment, including the high cost of IVF (typically $10,000-$20,000 per cycle) and the uncertainty of outcomes, while also offering eligibility for IVF refund programs if treatment fails. Both companies aim to enable more women and couples to afford multiple IVF cycles, as research shows up to 80% of patients quit after one unsuccessful cycle due to financial and emotional exhaustion.PR NewswireUnivfy and PracticeHwy Announce Partnership to Expand Access to Artificial Intelligence/Machine Learning Platform for Fertility Providers and PatientsUnivfy and PracticeHwy's eIVF announced a partnership to integrate Univfy's AI/ML platform into eIVF's electronic medical records, enabling automated generation of fertility counseling reports. The partnership aims to expand access to AI-assisted IVF counseling, and Univfy recently raised $6 million in Series B funding to support broader adoption.HomepageFertility Company Univfy Raises $6M in Series B Funding to Expand Its Platform Services to Health Plans and EmployersUnivfy raised $6M in Series B funding led by a portfolio company of Atlantic Street Capital. The company will use the funds to extend its AI/ML platform services to health plans and employers. The platform aims to bring transparency to fertility treatment costs and outcomes.PR NewswireUnivfy Raises $6M in Series B Financing to Expand Fertility Benefits and Advance Fertility PrognosticsUnivfy secured $6 million in Series B funding led by Atlantic Street Capital, enabling expansion of its AI/ML-fertility platform to broader markets including healthcare providers, insurance, and therapeutic development. The company aims to enhance fertility treatment success, patient counseling, and affordability globally. This funding will support development of predictive models and personalized fertility care services.PR NewswireUnivfy Nominated for 2020 Prix Galien USA "Best Digital Health Product" Award by the Galien FoundationUnivfy, an AI company specializing in fertility care based in Los Altos, California, was nominated by the Galien Foundation for the 2020 Prix Galien USA "Best Digital Health Product" award, with nominees announced in partnership with Business France. The nomination recognizes companies that have impacted patient care and the human condition through innovation. Univfy's PreIVF Report is an AI-assisted counseling tool that provides patients with personalized probability of success from IVF treatments based on their holistic health profiles.PR NewswireUnivfy and Gedeon Richter Announce Partnership to Launch Personalized In Vitro Fertilization (IVF) Counselling Platform to Support Fertility Patients and Providers in EuropeUnivfy Inc. and Gedeon Richter announced a partnership to launch an AI-powered IVF counseling platform in Europe, starting with European fertility centers in early 2021. The platform provides patients with personalized Univfy PreIVF Reports showing their probability of success across up to three IVF cycles, based on individual health profiles and validated against each center's clinical outcomes data. Gedeon Richter, a major pharmaceutical company headquartered in Hungary with a focus on women's health, will enable broader patient access to the technology that has already counseled more than 10,000 fertility patients in the U.S. and Canada.PR NewswireUnivfy to Speak at ACG New York Women of Leadership Summit and European HealthTech CEO Forum About Future of FemTech and HealthTechUnivfy, an AI platform company focused on in vitro fertilization, announced that cofounder and CEO Mylene Yao will speak at the ACG New York Women of Leadership Summit on January 16, 2020 in New York, discussing the FemTech industry and its growth forecast. Yao will also speak at the European HealthTech CEO Forum on February 18, 2020 in Zurich, Switzerland, participating in panels on the future vision of HealthTech and partnering with strategic partners.PR NewswireUnivfy to Present at Digital Medicine & Medtech Showcase 2020 on How AI and Fintech Make IVF Easier to Navigate for Patients and ProvidersUnivfy announced that its CEO, Dr. Mylene Yao, will present at the Digital Medicine & Medtech Showcase 2020 in San Francisco on January 14, 2020. The presentation will focus on how Univfy's AI and machine learning platform facilitates access to in-vitro fertilization (IVF) for patients and providers. Additionally, Univfy is scheduled to present at the Precision Medicine World Conference 2020 later in January.